Clinical Trial Update: Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and efficacy of inhaled prandial human insulin in Type 2 diabetes has been terminated. The sponsor is Novo Nordis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Inhaled prandial human insulin (insulin inhalation)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED